2.70 USD
↘ 0.01 (0.37%)PRE MARKET (AS OF 05:07 AM EDT)
Protalix BioTherapeutics, Inc. Common Stock
PLXAMEX • USD
Market: OPEN
Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $2.70. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.70
High?$2.79
Low?$2.67
Prev. Close?$2.71
Volume?904.3K
Avg. Volume?766.3K
VWAP?$2.70
Rel. Volume?1.18x
Bid / Ask
Bid?$2.58 × 300
Ask?$2.80 × 300
Spread?$0.22
Midpoint?$2.69
Valuation & Ratios
Market Cap?218.3M
Shares Out?80.6M
Float?75.0M
Float %?93.1%
P/E Ratio?11.53
P/B Ratio?3.06
EPS?$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Employees
226
Market Cap
218.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1996-01-02
Address
2 UNIVERSITY PLAZA
HACKENSACK, NJ 07601
Phone: 201-696-9345
HACKENSACK, NJ 07601
Phone: 201-696-9345
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?35
Short Sent.?74
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.45Safe
Confidence?53%Low
Short InterestModerate
Short % of Float?3.84%Low
Short Interest?2.9M
Days to Cover?3.8
Free Float75.0M
Avg Daily Volume754.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.94Strong
Quick Ratio?1.91Adequate
Cash Ratio?0.87Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?11.5CHEAP▾
Peers100
S&P92
P/B?3.06FAIR▾
Peers100
S&P55
P/S?2.71CHEAP▾
Peers100
S&P54
P/FCF?28.5FAIR▾
Peers100
S&P32
EV/EBITDA?7.7CHEAP▾
Peers100
S&P92
EV/Sales?2.37CHEAP▾
Peers100
S&P69
Returns & Efficiency
ROE?26.5%STRONG▾
Peers50
S&P76
ROA?17.2%STRONG▾
Peers50
S&P91
Cash Flow & Enterprise
FCF?$7.7M
Enterprise Value?$190.9M
Fundamentals ratios updated end of day